Welcome to
Allurion’s
Newsroom

Filter by language : AR / EN / ES / FR / IT
July 12, 2017

The Bloomberg Baystate Business Hour: Balloons and Robots

BLOOMBERG – Bloomberg Boston Bureau Chief Tom Moroney and Radio News Anchor Anne Mostue are joined by top names from local business and finance to medicine and politics, along with Bloomberg reporters covering the latest stories in and around Boston.

July 11, 2017

This Company Raised $27 Million for a Weight Loss Balloon You Can Swallow in a Pill

FORTUNE – Beyond diet and exercise, Americans who need to lose significant weight—whether to guard against diabetes, heart disease, or other obesity-related illnesses—don’t have a lot of ideal options. Bariatric surgery is invasive, risky, and expensive.

July 11, 2017

Allurion Raises $27 Million for Weight-Loss Tech

WSJ – Startup’s balloon-based system delivers weight loss without surgery

May 18, 2017

Swallowable gastric balloon could help the obese lose weight without surgery

THE GUARDIAN – Although not a replacement for bariatric surgery, temporary balloon could be used as early intervention or for those who do not want, or cannot have, surgery

April 7, 2017

VIDEO – Allurion co-founder Shantanu Gaur presents at SAGES 2016

March 31, 2017

Allurion Repays Massachusetts Life Sciences Center

MLSC – The Massachusetts Life Sciences Center (MLSC) and Natick-based Allurion Technologies announced that the company, which was awarded a $750,000 Accelerator loan from the MLSC in 2011, has repaid the loan with interest after a successful funding round from private investors.

March 1, 2017

VIDEO – Blue Mirror – Interview with Allurion co-founder Samuel Levy

START-UP FOOD

February 12, 2017

VIDEO – Balloon You Can Swallow Fights Obesity

NBC NEWS – Could a ‘Balloon in a Pill’ Be the Next Weight Loss Weapon?

February 7, 2017

More Data on Balloon-in-a-Pill Show Almost 15% Weight Loss

MEDSCAPE – Results from another small trial with a novel intragastric balloon that can be swallowed without the patient requiring endoscopy or anesthesia show that the 42 participants lost an average of 15.6 kg (34 lb), or over 14% of their body weight, over the 16-week duration of the trial.

The patients involved in the study had an average BMI of 38.6 kg/mat the start of the study and in this case were put on a ketogenic, very low-calorie diet (700 kcal/day) diet for the last 4 weeks of the trial.

February 7, 2017

Number To Know…10

MEDTECH INSIGHT – 10 minutes is the time it takes to prep the non-surgical, ingestible Elipse gastric balloon for obesity treatment. Elipse is developed by Allurion Technologies, which just bagged $19m in new funding.